Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/12/2018
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/12/2018
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/12/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/12/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/12/2018
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/12/2018
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
University of Alabama Medical Center
mi
from
Birmingham, AL
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
University of Alabama Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
Oregon Health Sciences University Medical Center
mi
from
Portland, OR
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
Oregon Health Sciences University Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
Pennsylvania Hospital
mi
from
Philadelphia, PA
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
Missouri Baptist Hospital
mi
from
Saint Louis, MO
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
Missouri Baptist Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated:  3/13/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
Status: Enrolling
Updated: 3/13/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Not Yet Recruiting
mi
from
Los Angeles, CA
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Not Yet Recruiting
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Not Yet Recruiting
mi
from
New Haven, CT
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Not Yet Recruiting
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Not Yet Recruiting
mi
from
Baltimore, MD
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Not Yet Recruiting
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Recruiting
mi
from
Canton, OH
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Recruiting
mi
from
Canton, OH
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Recruiting
mi
from
Miami, FL
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Recruiting
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Recruiting
mi
from
New York, NY
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Recruiting
mi
from
New York, NY
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Recruiting
mi
from
Oklahoma City, OK
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Recruiting
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Jacksonville, FL
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Tampa, FL
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Urbana, IL
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Urbana, IL
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Lexington, KY
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Detroit, MI
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Omaha, NE
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Brooklyn, NY
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Hilliard, OH
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Hilliard, OH
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Chattanooga, TN
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated:  3/13/2018
Site
mi
from
Milwaukee, WI
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer
Status: Enrolling
Updated: 3/13/2018
Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated:  3/13/2018
Hermann Professional Building Clinic
mi
from
Houston, TX
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated: 3/13/2018
Hermann Professional Building Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated:  3/13/2018
LBJ Hospital
mi
from
Houston, TX
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated: 3/13/2018
LBJ Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated:  3/13/2018
Texas Medical Center Clinic
mi
from
Houston, TX
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated: 3/13/2018
Texas Medical Center Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated:  3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated: 3/13/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated:  3/13/2018
Vancouver General Hospital/British Columbia Cancer Agency
mi
from
Vancouver,
Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer
Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis
Status: Enrolling
Updated: 3/13/2018
Vancouver General Hospital/British Columbia Cancer Agency
mi
from
Vancouver,
Click here to add this to my saved trials
Primary Breast Cancer Occurring Concomitant With Pregnancy
Multimodality Treatment of Primary Breast Cancer Occurring Concomitant With Pregnancy
Status: Enrolling
Updated:  3/14/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Primary Breast Cancer Occurring Concomitant With Pregnancy
Multimodality Treatment of Primary Breast Cancer Occurring Concomitant With Pregnancy
Status: Enrolling
Updated: 3/14/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Healthy Motivations for Moms-to-be Study
Healthy Motivations for Moms-to-be Study
Status: Enrolling
Updated:  3/14/2018
University of South Carolina
mi
from
Columbia, SC
Healthy Motivations for Moms-to-be Study
Healthy Motivations for Moms-to-be Study
Status: Enrolling
Updated: 3/14/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Iron Status and Myelination in Premature Infants
Double Blind Randomized Placebo Controlled Trial of Iron Supplementation in Premature Infants
Status: Enrolling
Updated:  3/15/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Iron Status and Myelination in Premature Infants
Double Blind Randomized Placebo Controlled Trial of Iron Supplementation in Premature Infants
Status: Enrolling
Updated: 3/15/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Evaluation of Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Status: Enrolling
Updated:  3/15/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Evaluation of Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Status: Enrolling
Updated: 3/15/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Click here to add this to my saved trials
Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)
Targeting Pathophysiologic Pathways in Polycystic Ovary Syndrome Using a Response to Metformin Phenotype
Status: Enrolling
Updated:  3/15/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)
Targeting Pathophysiologic Pathways in Polycystic Ovary Syndrome Using a Response to Metformin Phenotype
Status: Enrolling
Updated: 3/15/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Reducing Postoperative Catheterization
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated:  3/15/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Reducing Postoperative Catheterization
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated: 3/15/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Imaging of Lymphatic Anomalies
Dynamic Contrast Enhanced MR Lymphangiogram Imaging of Lymphatic Anomalies (LA)
Status: Enrolling
Updated:  3/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Imaging of Lymphatic Anomalies
Dynamic Contrast Enhanced MR Lymphangiogram Imaging of Lymphatic Anomalies (LA)
Status: Enrolling
Updated: 3/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
The Effect of Combination Therapy With Lifestyle Intervention and Metformin in Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  3/19/2018
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
The Effect of Combination Therapy With Lifestyle Intervention and Metformin in Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 3/19/2018
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Feeding and Wellness Among Late Preterm Infants
Early Feeding and Wellness Among Late Preterm Infants Born at MacDonald Women's Hospital: A Feasibility Study for a Breastfeeding Intervention
Status: Enrolling
Updated:  3/19/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Feeding and Wellness Among Late Preterm Infants
Early Feeding and Wellness Among Late Preterm Infants Born at MacDonald Women's Hospital: A Feasibility Study for a Breastfeeding Intervention
Status: Enrolling
Updated: 3/19/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Yale-New Haven Hospital North Haven Medical Center
mi
from
North Haven, CT
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Yale-New Haven Hospital North Haven Medical Center
mi
from
North Haven, CT
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Texas Oncology at Baylor Irving Cancer Center
mi
from
Irving, TX
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Texas Oncology at Baylor Irving Cancer Center
mi
from
Irving, TX
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Yale University
mi
from
New Haven, CT
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated:  3/20/2018
Baylor University Medical Center
mi
from
Dallas, TX
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease
Status: Enrolling
Updated: 3/20/2018
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery
Intrathecal Morphine Versus Intrathecal Hydromorphone for Analgesia Following Cesarean Delivery
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery
Intrathecal Morphine Versus Intrathecal Hydromorphone for Analgesia Following Cesarean Delivery
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials